Mechanical stress and formation of protein aggregates in neurodegenerative disorders

Medical Hypotheses

Volumn 70, Issue 5, 2008, Pages 1034-1037

  Hachiya, Naomi S ^a   Kozuka, Yoshimichi ^a   Kaneko, Kiyotoshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; POLYGLUTAMINE; TAU PROTEIN; TRINUCLEOTIDE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN SPONGIOSIS; DAILY LIFE ACTIVITY; DEGENERATIVE DISEASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HUMAN; INCIDENCE; MECHANICAL STRESS; MECHANORECEPTOR; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; QUALITY CONTROL; TRINUCLEOTIDE REPEAT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CATTLE; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEINS; STRESS, MECHANICAL;

BOVINAE;

EID: 40849086792     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.06.043     Document Type: Article

References (29)

1. Lustbader J.W., Cirilli M., Lin C., et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
2. Greenamyre J.T., and Hastings T.G. Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science 304 (2004) 1120-1122
3. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropath Exp Neurol 64 (2005) 649-664
4. Mayer M.P., Schroder H., Rudiger S., et al. Multistep mechanism of substrate binding determines chaperone activity of Hsp70. Nat Struct Biol 7 (2000) 586-593
5. Tanaka M., Kim Y.M., Lee G., et al. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279 (2004) 4625-4631
6. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl. (2004) S10-S17
7. Come J.H., Fraser P.E., and Lansbury Jr. P.T. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90 (1993) 5959-5963
8. Cohen F.E., Pan K.-M., Huang Z., et al. Structural clues to prion replication. Science 264 (1994) 530-531
9. Piazza O., Siren A.L., and Ehrenreich H. Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection?. Curr Med Res Opin 20 (2004) 505-508
10. Nelson L.M. Epidemiology of ALS. Clin Neurosci (New York, NY) 3 (1995) 327-331
11. Davanipour Z., Alter M., Sobel E., Asher D., and Gajdusek D.C. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 35 (1985) 1483-1486
12. Chio A., Benzi G., Dossena M., Mutani R., and Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128 (2005) 472-476
13. Vanacore N., Binazzi A., Bottazzi M., and Belli S. Amyotrophic lateral sclerosis in an Italian professional soccer player. Parkinsonism Relat Disord 12 (2006) 327-329
14. Clausen H., McCrory P., and Anderson V. The risk of chronic traumatic brain injury in professional boxing: change in exposure variables over the past century. Brit J Sports Med 39 (2005) 661-664 discussion 664
15. Viano D.C., Casson I.R., Pellman E.J., et al. Concussion in professional football: comparison with boxing head impacts--part 10. Neurosurgery 57 (2005) 1154-1172 discussion 1154-72
16. Tokuda T., Ikeda S., Yanagisawa N., Ihara Y., and Glenner G.G. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol (Berl) 82 (1991) 280-285
17. Bouras C., Giannakopoulos P., Good P.F., et al. A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Euro Neurol 38 (1997) 53-58
18. Goodwin L. Dementia pugilistica. J Insur Med (New York, NY) 38 (2006) 300-302
19. Uitti R.J., and Calne D.B. Pathogenesis of idiopathic parkinsonism. Euro Neurol 33 Suppl. 1 (1993) 6-23
20. Uryu K., Giasson B.I., Longhi L., et al. Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol 184 (2003) 214-224
21. Sasaki S., and Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66 (2007) 10-16
22. Sawada Y., Tamada M., Dubin-Thaler B.J., et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127 (2006) 1015-1026
23. Lutz R.E. Trinucleotide repeat disorders. Semin Pediatr Neurol 14 (2007) 26-33
24. Andrew S.E., Goldberg Y.P., Kremer B., et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4 (1993) 398-403
25. Duyao M., Ambrose C., Myers R., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4 (1993) 387-392
26. Orr H.T., Chung M.Y., Banfi S., et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4 (1993) 221-226
27. Snell R.G., MacMillan J.C., Cheadle J.P., et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 4 (1993) 393-397
28. Squitieri F., Ciarmiello A., Di Donato S., and Frati L. The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction. Eur J Neurol 13 (2006) 408-415
29. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 (2004) 1055-1063